IRIX
IRIDEX CORP
NASDAQ · Healthcare · Medical - Devices · US
$0.71
+1.29%Nov 3, 2026, 21:05 UTC
Iridex announced that it will release its third-quarter 2026 financial results and provide a business update after the close of trading on November 17, 2026.
Source:Oct 5, 2026, 11:00 UTC
Iridex completed the relocation of its manufacturing facility to San Jose, California, expecting about $600,000 in annualized cost savings.
Source:Sep 2, 2026, 20:36 UTC
IRIDEX Corp received a notice from NASDAQ on 2026-08-27 stating it no longer meets the minimum bid price requirement under Rule 5550(a)(2), and has until 2027-02-23 to regain compliance.
Aug 18, 2026, 20:05 UTC
Iridex Corporation reported its financial results for the second quarter ended July 4, 2026.
Jul 20, 2026, 11:00 UTC
Iridex Corporation expanded its EyeProGPO product offering to include its EndoProbe Handpieces.
Source: